Alkahest Overview

  • Founded

  • 2014

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 71

Employees
  • Latest Deal Type

  • M&A

  • Latest Deal Amount

  • $146M

  • Investors

  • 1

Alkahest General Information

Description

Owner and operator of a biotechnology company intended to enrich the health and vitality of humankind through transformative therapies that counterbalance the aging process. The company's therapies are used to augment the factors in the blood plasma in order to reverse detrimental effects of aging in both normal aging and disease models in animals, enabling doctors to improve vitality and find treatment for diseases of aging.

Contact Information

Website
www.alkahest.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Grifols
Primary Office
  • 125 Shoreway Road
  • Suite D
  • San Carlos, CA 94070
  • United States
+1 (650) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alkahest Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 15-Dec-2020 $146M 000.00 00000 Completed Clinical Trials - Phase 2
3. Grant 12-Feb-2018 000.00 Completed Clinical Trials - Phase 2
2. Corporate 23-Nov-2015 $35.9M $39.4M 000.00 Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 10-Jul-2014 $3.5M $3.5M Completed Clinical Trials - Phase 2
To view Alkahest’s complete valuation and funding history, request access »

Alkahest Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Owner and operator of a biotechnology company intended to enrich the health and vitality of humankind through transforma
Drug Discovery
San Carlos, CA
71 As of 2020
000.00
0000 0000-00-00
000000&0 000.00

000000

ation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderi
0000000000000
Redwood City, CA
00 As of 0000
0000
000 0000-00-00
00000000000 0000

000000

m veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis au
0000 000000000
Cambridge, MA
00 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Alkahest Competitors (45)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Tranquis Venture Capital-Backed Redwood City, CA 00 0000 00000000000 0000
00000000 000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
0000000 Venture Capital-Backed Emeryville, CA 00 00000 00000000000 00000
0000000000 Formerly VC-backed Cambridge, MA 00 0000 000000&0 0000
0000000000 Venture Capital-Backed Lausanne, Switzerland 00 000.00 0000000000 000.00
You’re viewing 5 of 45 competitors. Get the full list »

Alkahest Patents

  • 180

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 14

    Granted

  • 9

    Pending

  • 000

    Expiring in next 12 mo

Alkahest Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210301013-A1 Methods and compositions for treating aging-associated impairments with trefoil factor family member 2 modulators Pending 26-Nov-2019 00000000000
US-20210171626-A1 Methods and compositions for treating aging-associated impairments with trefoil factor family member 2 modulators Pending 26-Nov-2019 000000000
AU-2020393882-A1 Methods and compositions for treating aging-associated impairments with trefoil factor family member 2 modulators Pending 26-Nov-2019 000000000
CA-3156923-A1 Methods and compositions for treating aging-associated impairments with trefoil factor family member 2 modulators Pending 26-Nov-2019 000000000
AU-2020388572-A1 Blood plasma fractions for use in liver regeneration Pending 20-Nov-2019 A61P1/16
To view Alkahest’s complete patent history, request access »

Alkahest Executive Team (9)

Name Title Board Seat Contact Info
Steven Braithwaite Ph.D Chief Scientific Officer
Debbie Wallace Controller & Vice President of Finance
Tamara Kent Vice President, Human Resources
Tony Wyss-Coray Ph.D Co-Founder, Board Member & Chairman of Scientific Advisory Board
Cesar Cerezo MD Chief Medical Officer
You’re viewing 5 of 9 executive team members. Get the full list »

Alkahest Board Members (5)

Name Representing Role Since
David Bell Grifols Board Member 000 0000
Karoly Nikolich Ph.D Self Co-Founder, Chief Executive Officer & Chairman 000 0000
Tony Wyss-Coray Ph.D Alkahest Co-Founder, Board Member & Chairman of Scientific Advisory Board 000 0000
You’re viewing 3 of 5 board members. Get the full list »

Alkahest Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alkahest Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Michael J. Fox Foundation Limited Partner 000 0000 000000 0
Pivotal Life Sciences Venture Capital Minority 000 0000 000000 0
To view Alkahest’s complete investors history, request access »

Ready to get started?

Request a free trial